Pharmaceuticals

Trump warns pharmaceutical tariffs could reach 200%, gives 'a year to get their act together'

US President Donald Trump plans to implement a 200% tariff rate on pharmaceuticals, while he also announced tariffs on semiconductors and copper.

 US PRESIDENT Donald Trump in the Oval Office last Friday: Since Trump’s election as president last November for a second term, the US has no longer been committed to the previous world order in which it had played such a major role in creating and running, the writer maintains.
Doctor holds a stethoscope in front of a hospital background (illustrative)

Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses

 Pills on health form

Teva share price struggles to recover following $6 billion market loss

 AION Labs CTO Dr. Yair Benita

Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough


Immunai and Teva partner to innovate new cancer, immunology therapies

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

 An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Israeli mapping company ImmunAI partners with AstraZeneca

The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.

 Signing a lasting power of attorney

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.

Cancer (Illustrative)

Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care

Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.

  AI (Artificial Intelligence) letters are placed on computer motherboard in this illustration taken, June 23, 2023

Mounjaro: the next big thing in weight loss, now heading to Israel

Mounjaro is a new-generation injection that mimics two hormones in the body: GLP-1 and GIP. These hormones influence several processes in the body, including blood sugar regulation and satiety.

 Weight loss injections: Reducing sugar and increasing satiety.

Israel set to start selling pharmaceuticals outside of pharmacies

The Knesset Health Committee approved ordinances for the Pharmacists’ Regulations that would expand the list of active ingredients in drugs to be sold without a prescription and outside pharmacies

 Pills on health form

We must change the prejudices of mainstream medicine against lifestyle intervention - opinion

Lifestyle medicine prevents and reverses many chronic conditions and even auto-immune ones.

 DEAN ORNISH, president and founder of the Preventive Medicine Research Institute and a clinical professor of medicine at University of California, San Francisco, speaks during the Milken Institute Global Conference in Beverly Hills, in 2017.

Pharma companies challenge lawsuit alleging terrorism funding activities in US Supreme Court

The companies have denied wrongdoing and said they "are not responsible in any way for the tragic events that were caused and carried out by Iraqi militia groups."

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Teva joins world’s top 20 pharmaceutical companies 

After years of financial and legal problems, Israel’s Teva Pharmaceutical Industries Ltd. named No.19 among the world’s top 20 best-earning pharmaceutical companies.

 Medicine Pills

Medical hotline to assist patients and professionals reopens in Israel

The hotline, which had previously functioned only for emergencies, will reopen for expanded assistance starting this week.

Man talking on mobile phone.

The growth strategy of the Be Pharm chain: opens 3 new branches

As part of the strategy to expand its deployment all over the country, the Be Pharm chain opens three new branches that join the 96 active chain branches.

  Three new branches are opening in strategic locations for the pharmacy chain Be /